Skip to main content
Fig. 3 | Allergy, Asthma & Clinical Immunology

Fig. 3

From: The clinical burden of allergic rhinitis in five Middle Eastern countries: results of the SNAPSHOT program

Fig. 3

Impact of allergic rhinitis on quality of life. Quality of life was assessed using the three level EuroQol Five Dimension questionnaire (EQ-5D-3L) a EQ-5D-3L utility values for the allergic rhinitis (AR) population and general population by country b EQ-VAS scores for the AR population and general population by country. For the AR population (n = 1808) the data represent the mean EQ-5D-3L utility value and EQ-VAS score with the 95% CI. For the general population (n = 33,486), the mean EQ-5D-3L utility value and EQ-VAS score is presented. The p values were calculated using the Kruskall–Wallis test. Permission to use the EQ-5D-3L was provided by the EuroQol Research Foundation (© EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research Foundation)

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us